Pharmacologic inhibition of FLT3 by crenolanib and sorafenib, rescued ceramide generation, increased the levels of CERS1 mRNA and protein, and led to mitophagy and cell death in AML cells [162]. The gene discussed is FLT3; the disease is acute myeloid leukemia.